相似文献
1
More on sulfinpyrazone after myocardial infarction.
N Engl J Med. 1982 Apr 22;306(16):988-9. doi: 10.1056/NEJM198204223061611.
2
Sulfinpyrazone after myocardial infarction.
N Engl J Med. 1978 Jun 1;298(22):1257-9. doi: 10.1056/NEJM197806012982212.
3
Sulfinpyrazone after myocardial infarction: no decision yet.
N Engl J Med. 1980 Dec 18;303(25):1476-7. doi: 10.1056/NEJM198012183032510.
4
Anturane reinfarction trial.
N Engl J Med. 1981 Mar 19;304(12):730. doi: 10.1056/NEJM198103193041212.
5
The anturane reinfarction trial.
N Engl J Med. 1980 Jul 3;303(1):49.
6
The anturane reinfarction trial.
N Engl J Med. 1980 Jul 3;303(1):48.
7
Sulphinpyrazone (Anturan) after myocardial infarction.
N Z Med J. 1979 Sep 26;90(644):263.
8
The anturane reinfarction trial.
N Engl J Med. 1980 Jul 3;303(1):48.
9
Myocardial re-infarction and sulphinpyrazone.
N Z Med J. 1978 Aug 9;88(617):106.
10
The FDA's critique of the anturane reinfarction trial.
N Engl J Med. 1980 Dec 18;303(25):1488-92. doi: 10.1056/NEJM198012183032534.
引用本文的文献
1
Antithrombotic treatment.
Br Med J (Clin Res Ed). 1983 Jul 16;287(6386):196-8. doi: 10.1136/bmj.287.6386.196.
Zotero 插件